{"id":"https://openalex.org/W2074738183","doi":"https://doi.org/10.1177/155005949502600204","title":"Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic Outcome","display_name":"Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic Outcome","alternate_titles":[],"publication_year":1995,"publication_date":"1995-04-01","ids":{"openalex":"https://openalex.org/W2074738183","doi":"https://doi.org/10.1177/155005949502600204","mag":"2074738183","pmid":"https://pubmed.ncbi.nlm.nih.gov/7781194"},"language":"en","primary_location":{"id":"doi:10.1177/155005949502600204","doi":"https://doi.org/10.1177/155005949502600204","is_oa":false,"landing_page_url":"https://doi.org/10.1177/155005949502600204","pdf_url":null,"source":{"id":"https://openalex.org/S4210184100","display_name":"Clinical Electroencephalography","issn_l":"0009-9155","issn":["0009-9155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Electroencephalography","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2074738183"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008449767","display_name":"Stephen C. Suffin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen C. Suffin","raw_affiliation_strings":["Ventura Institute of Psychiatry Medical Group, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ventura Institute of Psychiatry Medical Group, Thousand Oaks, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053716230","display_name":"W. Hamlin Emory","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Hamlin Emory","raw_affiliation_strings":["Ventura Institute of Psychiatry Medical Group, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ventura Institute of Psychiatry Medical Group, Thousand Oaks, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3228,"has_fulltext":false,"cited_by_count":138,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77496274,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"26","issue":"2","first_page":"76","last_page":"83"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10581","display_name":"Neural dynamics and brain function","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-disorder","display_name":"attention deficit disorder","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.9940000176429749},{"id":"https://openalex.org/keywords/stimulants","display_name":"stimulants","score":0.652999997138977},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.9470000267028809},{"id":"https://openalex.org/keywords/treatment-outcome-prediction","display_name":"treatment outcome prediction","score":0.6470000147819519},{"id":"https://openalex.org/keywords/frontal-eeg","display_name":"frontal EEG","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.6628092527389526},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5685112476348877},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5119572877883911},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.502110481262207},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.452824205160141},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.34424644708633423},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3400043845176697},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.2740814685821533},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.10739171504974365}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019964","descriptor_name":"Mood Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019964","descriptor_name":"Mood Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/155005949502600204","doi":"https://doi.org/10.1177/155005949502600204","is_oa":false,"landing_page_url":"https://doi.org/10.1177/155005949502600204","pdf_url":null,"source":{"id":"https://openalex.org/S4210184100","display_name":"Clinical Electroencephalography","issn_l":"0009-9155","issn":["0009-9155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Electroencephalography","raw_type":"journal-article"},{"id":"pmid:7781194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7781194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical EEG (electroencephalography)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W13950049","https://openalex.org/W87481550","https://openalex.org/W644162623","https://openalex.org/W1554976072","https://openalex.org/W1965774235","https://openalex.org/W2021244134","https://openalex.org/W2040465910","https://openalex.org/W2064396657","https://openalex.org/W2068431486","https://openalex.org/W2097789984","https://openalex.org/W2100100838","https://openalex.org/W3202433750","https://openalex.org/W4298842621"],"related_works":["https://openalex.org/W2091402717","https://openalex.org/W3113366469","https://openalex.org/W2094405126","https://openalex.org/W2028841421","https://openalex.org/W2341158156","https://openalex.org/W29293979","https://openalex.org/W2124625400","https://openalex.org/W6925052283","https://openalex.org/W193219695","https://openalex.org/W7217691055"],"abstract_inverted_index":{"To":[0],"determine":[1],"if":[2],"quantitative":[3,43],"electrophysiologic":[4],"measures":[5],"correlate":[6],"with":[7,21,54,58,63,72,77,192],"pharmacotherapeutic":[8],"response,":[9],"we":[10],"conducted":[11],"a":[12,55,84],"retrospective":[13],"analysis":[14],"of":[15,201],"treatment":[16,82],"outcomes":[17],"in":[18],"sequential":[19],"patients":[20,31,50,68],"attention":[22],"deficit":[23],"disorder":[24],"and":[25,37,46,61,74,109,146],"affective":[26,38],"disorders.":[27],"One":[28],"hundred":[29],"medication-free":[30],"meeting":[32],"DSM-III-R":[33,130,206],"criteria":[34],"for":[35],"attentional":[36,108],"disorders":[39],"underwent":[40],"pretreatment":[41],"EEG,":[42,45],"Neurometric":[44,101,137,194],"physical/laboratory":[47],"examinations.":[48],"Attention-disordered":[49],"were":[51,69,87,103,115,133],"first":[52],"treated":[53,70],"stimulant,":[56],"secondarily":[57,75],"an":[59,64],"antidepressant,":[60,73],"tertially":[62],"anticonvulsant.":[65],"Affectively":[66],"disordered":[67,112],"initially":[71],"augmented":[76],"anticonvulsant":[78],"or":[79,176],"lithium.":[80],"Tertiary":[81],"was":[83,98,154,164,174,186],"stimulant.":[85],"Patients":[86,191],"assessed":[88],"up":[89],"to":[90,129,141,157,167,179,189,197],"6":[91],"months.":[92],"A":[93],"Clinical":[94],"Global":[95],"Improvement":[96],"score":[97],"assigned.":[99],"Similar":[100],"subgroups":[102],"identified":[104],"within":[105],"both":[106],"the":[107,110,198],"affectively":[111],"patients.":[113],"Subgroups":[114],"relative":[116,120],"alpha":[117,151,171],"frequency":[118,122],"excess,":[119,123],"theta":[121,161,183],"and/or":[124],"inter-hemispheric":[125],"hypercoherence.":[126],"Without":[127],"regard":[128],"diagnosis,":[131],"there":[132],"robust":[134],"correlations":[135],"between":[136],"subgroup":[138,153,163,173,185],"membership,":[139],"responsivity":[140],"selected":[142],"pharmacologic":[143],"agent":[144],"class(es),":[145],"clinical":[147],"outcome.":[148],"The":[149,159,169,181],"frontal":[150,160,170,182],"excess":[152,162],"87%":[155],"responsive":[156,166,178,188],"antidepressants.":[158],"100%":[165],"stimulants.":[168],"excess/hypercoherent":[172,184],"85%":[175],"more":[177],"anticonvulsants/lithium.":[180],"80%":[187],"anticonvulsants.":[190],"similar":[193],"features":[195],"responded":[196],"same":[199],"class(es)":[200],"psychopharmacologic":[202],"agent(s)":[203],"despite":[204],"their":[205],"classification.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2074738183","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
